- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Genomic Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Genomic Biomarker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Genomic Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protein Marker segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genomic Biomarker include Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genomic Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Protein Marker
Nucleic Acid Marker
Other
Market segment by Application, can be divided into
Hospitals
Diagnostic and research laboratories
Market segment by players, this report covers
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genomic Biomarker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genomic Biomarker, with revenue, gross margin and global market share of Genomic Biomarker from 2019 to 2022.
Chapter 3, the Genomic Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genomic Biomarker market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genomic Biomarker research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Genomic Biomarker
1.2 Classification of Genomic Biomarker by Type
1.2.1 Overview: Global Genomic Biomarker Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genomic Biomarker Revenue Market Share by Type in 2021
1.2.3 Protein Marker
1.2.4 Nucleic Acid Marker
1.2.5 Other
1.3 Global Genomic Biomarker Market by Application
1.3.1 Overview: Global Genomic Biomarker Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Global Genomic Biomarker Market Size & Forecast
1.5 Global Genomic Biomarker Market Size and Forecast by Region
1.5.1 Global Genomic Biomarker Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genomic Biomarker Market Size by Region, (2017-2022)
1.5.3 North America Genomic Biomarker Market Size and Prospect (2017-2028)
1.5.4 Europe Genomic Biomarker Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genomic Biomarker Market Size and Prospect (2017-2028)
1.5.6 South America Genomic Biomarker Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genomic Biomarker Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genomic Biomarker Market Drivers
1.6.2 Genomic Biomarker Market Restraints
1.6.3 Genomic Biomarker Trends Analysis
2 Company Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business
2.1.3 Bio-Rad Genomic Biomarker Product and Solutions
2.1.4 Bio-Rad Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Bio-Rad Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Genomic Biomarker Product and Solutions
2.2.4 Beckman Coulter Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Myriad Genetics
2.3.1 Myriad Genetics Details
2.3.2 Myriad Genetics Major Business
2.3.3 Myriad Genetics Genomic Biomarker Product and Solutions
2.3.4 Myriad Genetics Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Myriad Genetics Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Genomic Biomarker Product and Solutions
2.4.4 Thermo Fisher Scientific Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Genomic Biomarker Product and Solutions
2.5.4 Roche Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Roche Recent Developments and Future Plans
2.6 QIAGEN
2.6.1 QIAGEN Details
2.6.2 QIAGEN Major Business
2.6.3 QIAGEN Genomic Biomarker Product and Solutions
2.6.4 QIAGEN Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 QIAGEN Recent Developments and Future Plans
2.7 Epigenomics
2.7.1 Epigenomics Details
2.7.2 Epigenomics Major Business
2.7.3 Epigenomics Genomic Biomarker Product and Solutions
2.7.4 Epigenomics Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Epigenomics Recent Developments and Future Plans
2.8 Almac
2.8.1 Almac Details
2.8.2 Almac Major Business
2.8.3 Almac Genomic Biomarker Product and Solutions
2.8.4 Almac Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Almac Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Genomic Biomarker Product and Solutions
2.9.4 Pfizer Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Human Longevity
2.10.1 Human Longevity Details
2.10.2 Human Longevity Major Business
2.10.3 Human Longevity Genomic Biomarker Product and Solutions
2.10.4 Human Longevity Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Human Longevity Recent Developments and Future Plans
2.11 ValiRx
2.11.1 ValiRx Details
2.11.2 ValiRx Major Business
2.11.3 ValiRx Genomic Biomarker Product and Solutions
2.11.4 ValiRx Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 ValiRx Recent Developments and Future Plans
2.12 Personalis
2.12.1 Personalis Details
2.12.2 Personalis Major Business
2.12.3 Personalis Genomic Biomarker Product and Solutions
2.12.4 Personalis Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Personalis Recent Developments and Future Plans
2.13 Eagle Genomics
2.13.1 Eagle Genomics Details
2.13.2 Eagle Genomics Major Business
2.13.3 Eagle Genomics Genomic Biomarker Product and Solutions
2.13.4 Eagle Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Eagle Genomics Recent Developments and Future Plans
2.14 Empire Genomics
2.14.1 Empire Genomics Details
2.14.2 Empire Genomics Major Business
2.14.3 Empire Genomics Genomic Biomarker Product and Solutions
2.14.4 Empire Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Empire Genomics Recent Developments and Future Plans
2.15 Agilent
2.15.1 Agilent Details
2.15.2 Agilent Major Business
2.15.3 Agilent Genomic Biomarker Product and Solutions
2.15.4 Agilent Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Agilent Recent Developments and Future Plans
2.16 Illumina
2.16.1 Illumina Details
2.16.2 Illumina Major Business
2.16.3 Illumina Genomic Biomarker Product and Solutions
2.16.4 Illumina Genomic Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Illumina Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genomic Biomarker Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genomic Biomarker Players Market Share in 2021
3.2.2 Top 10 Genomic Biomarker Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genomic Biomarker Players Head Office, Products and Services Provided
3.4 Genomic Biomarker Mergers & Acquisitions
3.5 Genomic Biomarker New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genomic Biomarker Revenue and Market Share by Type (2017-2022)
4.2 Global Genomic Biomarker Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Genomic Biomarker Revenue Market Share by Application (2017-2022)
5.2 Global Genomic Biomarker Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Genomic Biomarker Revenue by Type (2017-2028)
6.2 North America Genomic Biomarker Revenue by Application (2017-2028)
6.3 North America Genomic Biomarker Market Size by Country
6.3.1 North America Genomic Biomarker Revenue by Country (2017-2028)
6.3.2 United States Genomic Biomarker Market Size and Forecast (2017-2028)
6.3.3 Canada Genomic Biomarker Market Size and Forecast (2017-2028)
6.3.4 Mexico Genomic Biomarker Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Genomic Biomarker Revenue by Type (2017-2028)
7.2 Europe Genomic Biomarker Revenue by Application (2017-2028)
7.3 Europe Genomic Biomarker Market Size by Country
7.3.1 Europe Genomic Biomarker Revenue by Country (2017-2028)
7.3.2 Germany Genomic Biomarker Market Size and Forecast (2017-2028)
7.3.3 France Genomic Biomarker Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genomic Biomarker Market Size and Forecast (2017-2028)
7.3.5 Russia Genomic Biomarker Market Size and Forecast (2017-2028)
7.3.6 Italy Genomic Biomarker Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genomic Biomarker Revenue by Type (2017-2028)
8.2 Asia-Pacific Genomic Biomarker Revenue by Application (2017-2028)
8.3 Asia-Pacific Genomic Biomarker Market Size by Region
8.3.1 Asia-Pacific Genomic Biomarker Revenue by Region (2017-2028)
8.3.2 China Genomic Biomarker Market Size and Forecast (2017-2028)
8.3.3 Japan Genomic Biomarker Market Size and Forecast (2017-2028)
8.3.4 South Korea Genomic Biomarker Market Size and Forecast (2017-2028)
8.3.5 India Genomic Biomarker Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genomic Biomarker Market Size and Forecast (2017-2028)
8.3.7 Australia Genomic Biomarker Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Genomic Biomarker Revenue by Type (2017-2028)
9.2 South America Genomic Biomarker Revenue by Application (2017-2028)
9.3 South America Genomic Biomarker Market Size by Country
9.3.1 South America Genomic Biomarker Revenue by Country (2017-2028)
9.3.2 Brazil Genomic Biomarker Market Size and Forecast (2017-2028)
9.3.3 Argentina Genomic Biomarker Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genomic Biomarker Revenue by Type (2017-2028)
10.2 Middle East & Africa Genomic Biomarker Revenue by Application (2017-2028)
10.3 Middle East & Africa Genomic Biomarker Market Size by Country
10.3.1 Middle East & Africa Genomic Biomarker Revenue by Country (2017-2028)
10.3.2 Turkey Genomic Biomarker Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genomic Biomarker Market Size and Forecast (2017-2028)
10.3.4 UAE Genomic Biomarker Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Genomic Biomarker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genomic Biomarker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genomic Biomarker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genomic Biomarker Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genomic Biomarker Revenue Market Share by Region (2023-2028)
Table 6. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 7. Bio-Rad Major Business
Table 8. Bio-Rad Genomic Biomarker Product and Solutions
Table 9. Bio-Rad Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter Genomic Biomarker Product and Solutions
Table 13. Beckman Coulter Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 15. Myriad Genetics Major Business
Table 16. Myriad Genetics Genomic Biomarker Product and Solutions
Table 17. Myriad Genetics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Genomic Biomarker Product and Solutions
Table 21. Thermo Fisher Scientific Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Genomic Biomarker Product and Solutions
Table 25. Roche Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 27. QIAGEN Major Business
Table 28. QIAGEN Genomic Biomarker Product and Solutions
Table 29. QIAGEN Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Epigenomics Corporate Information, Head Office, and Major Competitors
Table 31. Epigenomics Major Business
Table 32. Epigenomics Genomic Biomarker Product and Solutions
Table 33. Epigenomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Almac Corporate Information, Head Office, and Major Competitors
Table 35. Almac Major Business
Table 36. Almac Genomic Biomarker Product and Solutions
Table 37. Almac Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Genomic Biomarker Product and Solutions
Table 41. Pfizer Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Human Longevity Corporate Information, Head Office, and Major Competitors
Table 43. Human Longevity Major Business
Table 44. Human Longevity Genomic Biomarker Product and Solutions
Table 45. Human Longevity Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. ValiRx Corporate Information, Head Office, and Major Competitors
Table 47. ValiRx Major Business
Table 48. ValiRx Genomic Biomarker Product and Solutions
Table 49. ValiRx Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Personalis Corporate Information, Head Office, and Major Competitors
Table 51. Personalis Major Business
Table 52. Personalis Genomic Biomarker Product and Solutions
Table 53. Personalis Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Eagle Genomics Corporate Information, Head Office, and Major Competitors
Table 55. Eagle Genomics Major Business
Table 56. Eagle Genomics Genomic Biomarker Product and Solutions
Table 57. Eagle Genomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Empire Genomics Corporate Information, Head Office, and Major Competitors
Table 59. Empire Genomics Major Business
Table 60. Empire Genomics Genomic Biomarker Product and Solutions
Table 61. Empire Genomics Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Agilent Corporate Information, Head Office, and Major Competitors
Table 63. Agilent Major Business
Table 64. Agilent Genomic Biomarker Product and Solutions
Table 65. Agilent Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Illumina Corporate Information, Head Office, and Major Competitors
Table 67. Illumina Major Business
Table 68. Illumina Genomic Biomarker Product and Solutions
Table 69. Illumina Genomic Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Genomic Biomarker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Genomic Biomarker Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Genomic Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Genomic Biomarker Players Head Office, Products and Services Provided
Table 74. Genomic Biomarker Mergers & Acquisitions in the Past Five Years
Table 75. Genomic Biomarker New Entrants and Expansion Plans
Table 76. Global Genomic Biomarker Revenue (USD Million) by Type (2017-2022)
Table 77. Global Genomic Biomarker Revenue Share by Type (2017-2022)
Table 78. Global Genomic Biomarker Revenue Forecast by Type (2023-2028)
Table 79. Global Genomic Biomarker Revenue by Application (2017-2022)
Table 80. Global Genomic Biomarker Revenue Forecast by Application (2023-2028)
Table 81. North America Genomic Biomarker Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Genomic Biomarker Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Genomic Biomarker Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Genomic Biomarker Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Genomic Biomarker Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Genomic Biomarker Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Genomic Biomarker Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Genomic Biomarker Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Genomic Biomarker Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Genomic Biomarker Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Genomic Biomarker Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Genomic Biomarker Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Genomic Biomarker Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Genomic Biomarker Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Genomic Biomarker Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Genomic Biomarker Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Genomic Biomarker Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Genomic Biomarker Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Genomic Biomarker Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Genomic Biomarker Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Genomic Biomarker Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Genomic Biomarker Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Genomic Biomarker Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Genomic Biomarker Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Genomic Biomarker Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Genomic Biomarker Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Genomic Biomarker Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Genomic Biomarker Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Genomic Biomarker Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Genomic Biomarker Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Genomic Biomarker Picture
Figure 2. Global Genomic Biomarker Revenue Market Share by Type in 2021
Figure 3. Protein Marker
Figure 4. Nucleic Acid Marker
Figure 5. Other
Figure 6. Genomic Biomarker Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Diagnostic and research laboratories Picture
Figure 9. Global Genomic Biomarker Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Genomic Biomarker Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Genomic Biomarker Revenue Market Share by Region (2017-2028)
Figure 12. Global Genomic Biomarker Revenue Market Share by Region in 2021
Figure 13. North America Genomic Biomarker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Genomic Biomarker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Genomic Biomarker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Genomic Biomarker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Genomic Biomarker Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Genomic Biomarker Market Drivers
Figure 19. Genomic Biomarker Market Restraints
Figure 20. Genomic Biomarker Market Trends
Figure 21. Bio-Rad Recent Developments and Future Plans
Figure 22. Beckman Coulter Recent Developments and Future Plans
Figure 23. Myriad Genetics Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. QIAGEN Recent Developments and Future Plans
Figure 27. Epigenomics Recent Developments and Future Plans
Figure 28. Almac Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Human Longevity Recent Developments and Future Plans
Figure 31. ValiRx Recent Developments and Future Plans
Figure 32. Personalis Recent Developments and Future Plans
Figure 33. Eagle Genomics Recent Developments and Future Plans
Figure 34. Empire Genomics Recent Developments and Future Plans
Figure 35. Agilent Recent Developments and Future Plans
Figure 36. Illumina Recent Developments and Future Plans
Figure 37. Global Genomic Biomarker Revenue Share by Players in 2021
Figure 38. Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Genomic Biomarker Revenue Market Share in 2021
Figure 40. Global Top 10 Players Genomic Biomarker Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Genomic Biomarker Revenue Share by Type in 2021
Figure 43. Global Genomic Biomarker Market Share Forecast by Type (2023-2028)
Figure 44. Global Genomic Biomarker Revenue Share by Application in 2021
Figure 45. Global Genomic Biomarker Market Share Forecast by Application (2023-2028)
Figure 46. North America Genomic Biomarker Sales Market Share by Type (2017-2028)
Figure 47. North America Genomic Biomarker Sales Market Share by Application (2017-2028)
Figure 48. North America Genomic Biomarker Revenue Market Share by Country (2017-2028)
Figure 49. United States Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Genomic Biomarker Sales Market Share by Type (2017-2028)
Figure 53. Europe Genomic Biomarker Sales Market Share by Application (2017-2028)
Figure 54. Europe Genomic Biomarker Revenue Market Share by Country (2017-2028)
Figure 55. Germany Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Genomic Biomarker Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Genomic Biomarker Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Genomic Biomarker Revenue Market Share by Region (2017-2028)
Figure 63. China Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Genomic Biomarker Sales Market Share by Type (2017-2028)
Figure 70. South America Genomic Biomarker Sales Market Share by Application (2017-2028)
Figure 71. South America Genomic Biomarker Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Genomic Biomarker Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Genomic Biomarker Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Genomic Biomarker Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Genomic Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
